• Benign Prostatic Hyperplasia
  • Hormone Therapy
  • Genomic Testing
  • Next-Generation Imaging
  • UTUC
  • OAB and Incontinence
  • Genitourinary Cancers
  • Kidney Cancer
  • Men's Health
  • Pediatrics
  • Female Urology
  • Sexual Dysfunction
  • Kidney Stones
  • Urologic Surgery
  • Bladder Cancer
  • Benign Conditions
  • Prostate Cancer

Dr. McConnell receives triennial AUA award

Article

John McConnell, MD, professor of urology and executive vice president for health system affairs at the University of Texas Southwestern Medical Center, has received the AUA 2007 Eugene Fuller Triennial Prostate Award, which recognizes an individual who has made outstanding contributions to the study of the prostate gland and its associated diseases.

John McConnell, MD, professor of urology and executive vice president for health system affairs at the University of Texas Southwestern Medical Center, has received the AUA 2007 Eugene Fuller Triennial Prostate Award, which recognizes an individual who has made outstanding contributions to the study of the prostate gland and its associated diseases.

Dr. McConnell was cited by AUA for his innovative research studies of BPH and for his leadership in developing a multidisciplinary program at UT Southwestern that brought together basic and clinical research, innovative patient care, and health care policy in prostate disease. For a decade, the program he directed was designated as one of the country’s National Institutes of Health George M. O’Brien Urology Research Centers.

His research findings include the discovery that the combination of doxazosin (Cardura) and finasteride (Proscar) is more effective in treating BPH than is either drug alone.

Related Videos
Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
Gamal M. Ghoniem, MD, FACS, ABU/FPMRS, gives an answer during a video interview
Edward M. Schaeffer, MD, PhD, answers a question during a Zoom video interview
Zhina Sadeghi, MD, answers a question during a video interview
A panel of 4 experts on prostate cancer
A panel of 4 experts on prostate cancer
A panel of 4 experts on prostate cancer
A panel of 4 experts on prostate cancer
© 2024 MJH Life Sciences

All rights reserved.